Alyeska Investment Group
KALA icon

Alyeska Investment Group’s KALA BIO KALA Stock Holding History

Alyeska Investment Group’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-47
Closed -$799K – 788
2021
Q1 		$799K Hold
47
– – 0.01% 618
2020
Q4 		$803K Sell
47
-1
-2% -$18.8K 0.01% 427
2020
Q3 		$896K Buy
48
+4
+9% +$91.9K 0.01% 397
2020
Q2 		$1.15M Sell
44
-56
-56% -$1.59M 0.02% 397
2020
Q1 		$2.19M Sell
100
-75
-43% -$1.2M 0.04% 251
2019
Q4 		$1.61M Buy
175
+15
+9% +$145K 0.02% 309
2019
Q3 		$1.52M Buy
160
+20
+14% +$243K 0.02% 307
2019
Q2 		$2.23M Buy
140
+77
+122% +$1.28M 0.03% 312
2019
Q1 		$1.3M Hold
63
– – 0.02% 304
2018
Q4 		$768K Buy
+63
New +$1.09M 0.01% 321
2018
Q3 		– Sell
-60
Closed -$2.06M – 459
2018
Q2 		$2.06M Buy
60
+2
+3% +$76.7K 0.02% 350
2018
Q1 		$2.3M Sell
58
-18
-24% -$684K 0.02% 337
2017
Q4 		$3.51M Buy
76
+25
+49% +$1.17M 0.03% 282
2017
Q3 		$2.91M Buy
+51
New +$2.8M 0.02% 326

Other funds holding KALA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Alyeska Investment Group's KALA Position: Q2 2021 in Review

Alyeska Investment Group sold out of KALA BIO (KALA) in Q2 2021, closing a stake of 47 shares — an estimated $799K sold.

Alyeska Investment Group first reported a position in KALA in Q3 2017 and held it in 14 quarters. The position peaked at $3.51M in Q4 2017. 97 funds tracked by Wall St. Rank hold KALA as of Q2 2021.

  • Alyeska Investment Group reported no remaining KALA BIO position as of Q2 2021 after selling out during the quarter.
  • Alyeska Investment Group sold 47 KALA BIO shares in Q2 2021, an estimated $799K.
  • Alyeska Investment Group first reported a position in KALA BIO in Q3 2017 and held it in 14 quarters.
  • Alyeska Investment Group's KALA BIO position peaked at $3.51M in Q4 2017.
  • 97 funds tracked by Wall St. Rank held KALA BIO as of Q2 2021.

Based on Alyeska Investment Group's 13F filing for Q2 2021, filed 16 Aug 2021.